Wellington Management Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,223,324
| Closed | -$367M | – | 2356 |
|
|
2021
Q2 | $367M | Sell |
2,223,324
-17,848
| -0.8% | -$2.98M | 0.06% | 298 |
|
|
2021
Q1 | $344M | Sell |
2,241,172
-3,093,917
| -58% | -$420M | 0.06% | 303 |
|
|
2020
Q4 | $669M | Sell |
5,335,089
-135,188
| -2% | -$15.1M | 0.12% | 172 |
|
|
2020
Q3 | $555M | Buy |
5,470,277
+11,542
| +0.2% | +$1.18M | 0.11% | 165 |
|
|
2020
Q2 | $531M | Sell |
5,458,735
-270,477
| -5% | -$25.2M | 0.12% | 170 |
|
|
2020
Q1 | $476M | Buy |
5,729,212
+167,867
| +3% | +$16.4M | 0.13% | 161 |
|
|
2019
Q4 | $618M | Buy |
5,561,345
+1,218,638
| +28% | +$125M | 0.13% | 165 |
|
|
2019
Q3 | $431M | Buy |
4,342,707
+1,210,399
| +39% | +$120M | 0.1% | 213 |
|
|
2019
Q2 | $311M | Buy |
3,132,308
+242,020
| +8% | +$23.1M | 0.07% | 270 |
|
|
2019
Q1 | $319M | Sell |
2,890,288
-48,457
| -2% | -$5.06M | 0.07% | 269 |
|
|
2018
Q4 | $270M | Buy |
2,938,745
+331,861
| +13% | +$33.6M | 0.07% | 273 |
|
|
2018
Q3 | $287M | Buy |
2,606,884
+1,104,370
| +74% | +$115M | 0.06% | 305 |
|
|
2018
Q2 | $140M | Buy |
1,502,514
+38,607
| +3% | +$3.32M | 0.03% | 473 |
|
|
2018
Q1 | $121M | Sell |
1,463,907
-59,574
| -4% | -$5.29M | 0.03% | 517 |
|
|
2017
Q4 | $139M | Buy |
1,523,481
+189,418
| +14% | +$15.8M | 0.03% | 457 |
|
|
2017
Q3 | $102M | Buy |
1,334,063
+756,170
| +131% | +$57.1M | 0.02% | 544 |
|
|
2017
Q2 | $43.3M | Sell |
577,893
-16,552
| -3% | -$1.15M | 0.01% | 780 |
|
|
2017
Q1 | $38.8M | Buy |
594,445
+1,967
| +0.3% | +$116K | 0.01% | 814 |
|
|
2016
Q4 | $32.7M | Buy |
592,478
+41,225
| +7% | +$2.26M | 0.01% | 847 |
|
|
2016
Q3 | $31.2M | Sell |
551,253
-97,987
| -15% | -$4.81M | 0.01% | 835 |
|
|
2016
Q2 | $27.1M | Sell |
649,240
-361,155
| -36% | -$16.6M | 0.01% | 846 |
|
|
2016
Q1 | $43.2M | Sell |
1,010,395
-102,595
| -9% | -$4.33M | 0.01% | 716 |
|
|
2015
Q4 | $50.4M | Buy |
1,112,990
+113,219
| +11% | +$4.76M | 0.01% | 673 |
|
|
2015
Q3 | $38.8M | Sell |
999,771
-164,778
| -14% | -$6.6M | 0.01% | 759 |
|
|
2015
Q2 | $42.3M | Sell |
1,164,549
-301,946
| -21% | -$9.55M | 0.01% | 780 |
|
|
2015
Q1 | $42.3M | Buy |
1,466,495
+39,868
| +3% | +$1.11M | 0.01% | 783 |
|
|
2014
Q4 | $34.6M | Buy |
+1,426,627
| New | +$32.2M | 0.01% | 850 |
|
Other funds holding PRAH
Wellington Management Group's PRAH Position: Q3 2021 in Review
Wellington Management Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,223,324 shares — an estimated $367M sold.
Wellington Management Group first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $669M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Wellington Management Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Wellington Management Group sold 2,223,324 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $367M.
- Wellington Management Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Wellington Management Group's PRA Health Sciences, Inc. position peaked at $669M in Q4 2020.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Wellington Management Group's 13F filing for Q3 2021, filed 15 Nov 2021.